Cell Pathways (CLPA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Pathways (CLPA)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike J who wrote (49)	11/25/1998 2:35:00 AM
From: bob	Read Replies (1) of 566

MikeJ, I checked the Bayer website and e-mailed the company asking if they had any compounds in the pipeline specifically for the study or creation of apoptosis as it relates to cancer or pre-cancerous conditions. Nothing was found on their website and to date I have not recieved a response to my e-mail. You may be thinking of the new COX-2 inhibitors that will be used as anti-inflammatories. If a company wanted to bring this to market as a treatment for the prevention of cancer or any other condition it would take them several years (CLPA has been doing the research for 8) to catch up to CLPA as they would have to go through PhaseI/II/III trials just as CLPA has done before the drug could be approved. We are way ahead of the game here and unless I am mistaken WE DO NOT HAVE ANY COMPETITION in the field of chemoprevention at this time. Not a bad spot to be in... Bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next